Panbela Therapeutics Management
Management criteria checks 4/4
Panbela Therapeutics' CEO is Jennifer Simpson, appointed in Jul 2020, has a tenure of 3.83 years. total yearly compensation is $571.92K, comprised of 92.1% salary and 7.9% bonuses, including company stock and options. directly owns 0% of the company’s shares, worth $2.58. The average tenure of the management team and the board of directors is 3.8 years and 4.4 years respectively.
Key information
Jennifer Simpson
Chief executive officer
US$571.9k
Total compensation
| CEO salary percentage | 92.1% |
| CEO tenure | 3.8yrs |
| CEO ownership | 0.0001% |
| Management average tenure | 3.8yrs |
| Board average tenure | 4.4yrs |
Recent management updates
Recent updates
Panbela Therapeutics dips 24% on pricing $6M public offering
Sep 30Panbela Therapeutics GAAP EPS of -$1.51
Aug 15Companies Like Panbela Therapeutics (NASDAQ:PBLA) Are In A Position To Invest In Growth
Feb 18
Panbela: Biotech With Updated Patent Protection And Unmet Market Target Indication
Jan 06Will Panbela Therapeutics (NASDAQ:PBLA) Spend Its Cash Wisely?
Nov 02Companies Like Panbela Therapeutics (NASDAQ:PBLA) Are In A Position To Invest In Growth
Jul 15Panbela Therapeutics to join Russell Microcap Index
Jun 09We Think Panbela Therapeutics (NASDAQ:PBLA) Can Afford To Drive Business Growth
Mar 29CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$572k | US$527k | -US$34m |
| Sep 30 2023 | n/a | n/a | -US$24m |
| Jun 30 2023 | n/a | n/a | -US$20m |
| Mar 31 2023 | n/a | n/a | -US$36m |
| Dec 31 2022 | US$694k | US$506k | -US$35m |
| Sep 30 2022 | n/a | n/a | -US$34m |
| Jun 30 2022 | n/a | n/a | -US$31m |
| Mar 31 2022 | n/a | n/a | -US$12m |
| Dec 31 2021 | US$1m | US$477k | -US$10m |
| Sep 30 2021 | n/a | n/a | -US$7m |
| Jun 30 2021 | n/a | n/a | -US$7m |
| Mar 31 2021 | n/a | n/a | -US$5m |
| Dec 31 2020 | US$2m | US$146k | -US$5m |
Compensation vs Market: Jennifer's total compensation ($USD571.92K) is about average for companies of similar size in the US market ($USD661.60K).
Compensation vs Earnings: Jennifer's compensation has been consistent with company performance over the past year.
CEO
Jennifer Simpson (55 yo)
3.8yrs
Tenure
US$571,921
Compensation
Dr. Jennifer K. Simpson, Ph.D. M.S.N. C.R.N.P. has been the Chief Executive Officer, President and Director of Panbela Therapeutics, Inc. (formerly known as Sun BioPharma, Inc.) since July 15, 2020. She se...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 3.8yrs | US$571.92k | 0.00014% $ 2.6 | |
| VP of Finance | 6.1yrs | US$467.92k | 0.00014% $ 2.6 | |
| Vice President of Operations | no data | no data | no data | |
| VP & Chief Scientific Officer | 1.9yrs | no data | no data |
3.8yrs
Average Tenure
Experienced Management: PBLA's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 3.8yrs | US$571.92k | 0.00014% $ 2.6 | |
| Vice Chair & Lead Independent Director | 8.7yrs | US$85.14k | 0% $ 0 | |
| Chairman | 8.7yrs | US$76.14k | 0.00045% $ 8.3 | |
| Director | 1.9yrs | US$43.63k | 0.000020% $ 0.4 | |
| Independent Director | 1.9yrs | US$56.13k | 0.00023% $ 4.2 | |
| Independent Director | 4.4yrs | US$52.63k | 0% $ 0 | |
| Independent Director | 8.7yrs | US$61.13k | 0.00045% $ 8.3 | |
| Scientific Advisor | no data | no data | no data | |
| Scientific Advisor | no data | no data | no data | |
| Scientific Advisor | no data | no data | no data |
4.4yrs
Average Tenure
62yo
Average Age
Experienced Board: PBLA's board of directors are considered experienced (4.4 years average tenure).